Skip to main content

Table 2 HIV status disclosure, partner HIV testing and stigma at month 2 and 4 follow up visits

From: HIV status disclosure and associated outcomes among pregnant women enrolled in antiretroviral therapy in Uganda: a mixed methods study

Characteristic

Follow up

At month 2 post-enrolment

Frequencies (%)

At month 4 post-enrolment

Frequencies (%)

Partner testing

 Overall

407 (100)

389 (100)

 Yes

195 (47.9)

184 (47.3)

 No

77 (18.9)

93 (23.9)

 Don’t know

135 (33.1)

112 (28.8)

How partner tested

 Tested together during ANC

27 (12.0)

31 (19.1)

 Tested together outside ANC

34 (10.0)

19 (11.7)

 Tested individually

118 (55.0)

112 (69.1)

Partner HIV status

 HIV negative

104 (53.6)

86 (46.7)

 HIV positive

82 (42.3)

86 (46.7)

 Don’t know

8 (4.1)

12 (6.5)

HIV status disclosed

 Yes

353 (74.5)

375 (83.7)

Disclosure by study site

 Mityana hospital

157 (79.7)

156 (83.9)

 Masaka hospital

132 (82.0)

142 (88.8)

 Luwero H/C IV

64 (64.0)

77 (77.0)

Persons most commonly disclosed to

 Spouses

353 (59.5)

374 (58.0)

 Sisters

353 (36.8)

373 (42.1)

 Mothers

302 (37.7)

330 (39.4)

 Friends

353 (14.4)

374 (18.7)

 Brothers

352 (12.5)

373 (18.0)

 Fathers

269 (9.3)

286 (11.9)

Number of people disclosed to

 0

14 (3.9)

11 (2.9)

 1

194 (54.8)

187 (49.6)

 2

88 (24.9)

104 (27.6)

 3

36 (10.2)

36 (9.6)

 4

17 (4.8)

25 (6.6)

 5

4 (1.1)

12 (3.2)

 6

1 (0.3)

2 (0.5)

Self-reported adverse events

 HIV-related stigma

35 (7.6)

49 (10.8)

 Discrimination

25 (5.4)

24 (5.3)

 Violence

18 (3.9)

17 (3.7)